Cybernews researchers found an exposed database with 24 billion credential records, raising fresh risks from password reuse ...
The Passwords app will change weak or compromised passwords for your online accounts. We've had mixed results when asking AI ...
Modern infostealers don't just steal passwords—they harvest the digital identities and context that enable attackers to blend ...
Apple’s Passwords app got one of the best new AI features at WWDC 2026, and it could be a revolutionary way to protect your ...
Apps from Apple, Google and others can assist in making your online accounts more secure, even as new ways of logging in continue to take off. By J. D. Biersdorfer J.D. Biersdorfer writes about how to ...
UPDATE: May. 6, 2026, 9:40 a.m. EDT This piece was updated to include a statement from Microsoft. Password managers are supposed to make life easier for users by remembering their passwords and ...
We wouldn't blame you for assuming that AI, being a computer, would be better at generating passwords than a human. After all, people use AI to do everything from writing their emails to generating a ...
Still looking? See more results on Wirecutter. We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...
The era of AI has not been particularly great for cybersecurity. We know that vibe-coded websites and apps have been a hotbed of security flaws that leave the platforms vulnerable to attacks. It turns ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...